Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Matera

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Pulmonary Pharmacology & Therapeutics|December 21, 2002
Innervation of equine airwaysM G Matera, M Amorena, A Lucisano
Clinical Therapeutics|January 1, 1991
Bronchial hyperresponsiveness and bacterial respiratory infectionsM Cazzola, M G Matera, F Rossi
Drugs of Today (Barcelona, Spain : 1998)|September 18, 2015
Fluticasone furoate/vilanterol combination for the treatment of COPD and asthmaP Rogliani, M G Matera, M Cazzola
Drugs of Today (Barcelona, Spain : 1998)|May 15, 2010
Indacaterol for chronic obstructive pulmonary disease (COPD)Mario Cazzola, A Proietto, M G Matera
International Journal of Tissue Reactions|January 1, 1993
Role of M1 muscarinic receptor subtypes in mediating airway smooth muscle contractionM G Matera, M Cazzola, F Rossi
Respiratory Medicine|September 1, 1996
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary diseaseM G Matera, M Caputi, M Cazzola
Thorax|July 22, 1999
Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary diseaseM Cazzola, C F Donner, M G Matera
Clinical Drug Investigation|March 29, 2008
Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infectionsM Cazzola, M G Matera, C F Donner
Allergy|January 1, 1995
Effects of serotonin on airways: recent developmentsM Cazzola, M G Matera, G D'Amato, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effect of flomoxef on human platelet aggregationM Cazzola, M G Matera, A Gusmitta, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Pulmonary Pharmacology & Therapeutics|December 21, 2002
Innervation of equine airwaysM G Matera, M Amorena, A Lucisano
Clinical Therapeutics|January 1, 1991
Bronchial hyperresponsiveness and bacterial respiratory infectionsM Cazzola, M G Matera, F Rossi
Drugs of Today (Barcelona, Spain : 1998)|September 18, 2015
Fluticasone furoate/vilanterol combination for the treatment of COPD and asthmaP Rogliani, M G Matera, M Cazzola
Drugs of Today (Barcelona, Spain : 1998)|May 15, 2010
Indacaterol for chronic obstructive pulmonary disease (COPD)Mario Cazzola, A Proietto, M G Matera
International Journal of Tissue Reactions|January 1, 1993
Role of M1 muscarinic receptor subtypes in mediating airway smooth muscle contractionM G Matera, M Cazzola, F Rossi
Respiratory Medicine|September 1, 1996
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary diseaseM G Matera, M Caputi, M Cazzola
Thorax|July 22, 1999
Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary diseaseM Cazzola, C F Donner, M G Matera
Clinical Drug Investigation|March 29, 2008
Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infectionsM Cazzola, M G Matera, C F Donner
Allergy|January 1, 1995
Effects of serotonin on airways: recent developmentsM Cazzola, M G Matera, G D'Amato, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effect of flomoxef on human platelet aggregationM Cazzola, M G Matera, A Gusmitta, et al.
Pageof 12